ASAT AG APPLIED SCIENCE & TECH has a total of 65 patent applications. Its first patent ever was published in 1998. It filed its patents most often in Germany, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, medical technology and organic fine chemistry are INST ADVANCED SKIN RES INC, SKINVISIBLE PHARMACEUTICALS IN and MANN MORRIS A.
# | Country | Total Patents | |
---|---|---|---|
#1 | Germany | 7 | |
#2 | United States | 7 | |
#3 | WIPO (World Intellectual Property Organization) | 7 | |
#4 | EPO (European Patent Office) | 6 | |
#5 | Canada | 5 | |
#6 | China | 4 | |
#7 | Australia | 3 | |
#8 | Israel | 3 | |
#9 | New Zealand | 3 | |
#10 | Brazil | 2 | |
#11 | Ecuador | 2 | |
#12 | Croatia | 2 | |
#13 | Republic of Korea | 2 | |
#14 | Mexico | 2 | |
#15 | Norway | 2 | |
#16 | Poland | 2 | |
#17 | Tunisia | 2 | |
#18 | Costa Rica | 1 | |
#19 | Hong Kong | 1 | |
#20 | Iceland | 1 | |
#21 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Organic fine chemistry | |
#4 | Machines | |
#5 | Biotechnology | |
#6 | Computer technology | |
#7 | Micro-structure and nano-technology |
# | Name | Total Patents |
---|---|---|
#1 | Schmid Hans W | 40 |
#2 | Berchtold Peter | 8 |
#3 | Burmeister Gerd | 7 |
#4 | Escher Robert F A | 7 |
#5 | Elsner Peter | 5 |
#6 | Hans W Schmid | 3 |
#7 | Escher Robert | 2 |
#8 | Gerd Burmeister | 1 |
#9 | Berchtold Peter Dr Med | 1 |
#10 | Bunke Antje | 1 |
Publication | Filing date | Title |
---|---|---|
AU2003278164A1 | Daily melatonin dosing units | |
CN101897736A | Formulations containing melatonin, ginkgo biloba, and biotin | |
DE10250646A1 | Cosmetic and/or pharmaceutical hair treatment compositions, especially for promoting hair growth, containing melatonin (or derivative) and Gingko biloba and biotin as potentiating agents | |
US2004043390A1 | Use of nucleotide sequences as carrier of cultural information | |
DE10110418A1 | Melatonin Vitamin A supplements | |
DE10057443A1 | Use of specific antibodies, or individual chains, for treating tumors and vascular occlusions, by inhibition of the gpIIb/IIIa receptor | |
DE10003620A1 | Non-aqueous solution or suspension of 5-aminolevulinic acid, is useful in the treatment or diagnosis of tumor diseases or psoriasis by photodynamic therapy | |
DE19957710A1 | Treating female type androgenetic or diffuse alopecia by topical administration of melatonin, causing e.g. reduction of telogen rate and increase of anagen rate, hair diameter and tensile strength | |
DE19852245A1 | 5-aminolevulinic acid nanoemulsion | |
AU8436798A | Anti-GPIIb/IIIa recombinant antibodies | |
DE19820663A1 | Recombinant antibodies |